Herbert Hooijkaas
About
In The Last Decade
Herbert Hooijkaas
149 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Immunology 2.1k
- Endocrinology, Diabetes and Metabolism 1.3k
- Neurology 1.1k
- Public Health, Environmental and Occupational Health 1.1k
- Molecular Biology 1.1k
Countries citing papers authored by Herbert Hooijkaas
This map shows the geographic impact of Herbert Hooijkaas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Hooijkaas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Hooijkaas more than expected).
Fields of papers citing papers by Herbert Hooijkaas
This network shows the impact of papers produced by Herbert Hooijkaas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Hooijkaas. The network helps show where Herbert Hooijkaas may publish in the future.
Co-authorship network of co-authors of Herbert Hooijkaas
This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Hooijkaas. A scholar is included among the top collaborators of Herbert Hooijkaas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Hooijkaas. Herbert Hooijkaas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 34 | |
| 3 | 34 | |
| 4 | 69 | |
| 5 | Orbital Fibroblasts Intrinsically Differ From Dermal Fibroblasts By A Unique Protein Production Profile | 1 |
| 6 | 24 | |
| 7 | Immunogenicity of toxins during Staphylococcus aureus infection | 2 |
| 8 | Therapeutic antibodies and fusion proteins: what are they and how do they work | 2 |
| 9 | 57 | |
| 10 | Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus | 9 |
| 11 | 150 | |
| 12 | 50 | |
| 13 | 3 | |
| 14 | 11 | |
| 15 | 359 | |
| 16 | 56 | |
| 17 | 30 | |
| 18 | 170 | |
| 19 | 31 | |
| 20 | Deficiency of immunity to Mycobacterium avium that can be restored by allogeneic lymphocytes. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.